Dow Down1.40% Nasdaq Down1.59%

More On QRX.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


QRxPharma Limited (QRX.AX)

-ASX
0.02 0.00(0.00%) Oct 1
ProfileGet Profile for:
QRxPharma Limited
100 Walker Street
Level 11
North Sydney, NSW 2060
Australia - Map
Phone: 61 2 8404 4139
Fax: 61 2 8920 0314
Website: http://www.qrxpharma.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Drugs - Generic
Full Time Employees:N/A

Business Summary 

QRxPharma Limited develops and commercializes biopharmaceutical products primarily in Australia. It develops proprietary Dual Opioid formulations for treating patients with moderate to severe acute or chronic pain. The company develops pain management products consisting of Moxduo Immediate Release, an oral capsule for the treatment of moderate to severe acute pain; Moxduo Controlled Release oral tablet for chronic pain; and Moxduo Intravenous formulation for hospital-based, post-surgical pain, as well as Pro-drug/Hybrid Dual Opioids. It also offers abuse prevention products, including Stealth Beadlets abuse deterrent technology. QRxPharma Limited is based in North Sydney, Australia.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on QRxPharma Limited

Key Executives 
 PayExercised
Dr. Edward M. Rudnic Ph.D., 58
Chief Exec. Officer
441.00KN/A
Mr. Chris J. Campbell CA,
Chief Financial Officer and Company Sec.
287.00KN/A
Dr. Beth A. Burnside Ph.D., 53
Sr. VP of Regulatory Affairs and Compliance
65.00KN/A
Ms. M. Janette Dixon Ph.D.,
Sr. VP of Global Bus. Devel.
326.00KN/A
Dr. Gary W. Pace Ph.D., 66
Consultant
47.00KN/A
Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in AUD.